Profile
Peter Greaney worked as the Director of Business Development and Operations at Celgene Corp.
from 2006 to 2018.
He also worked as the Head of Corporate Development at ADC Therapeutics SA. Prior to his professional experience, he earned an undergraduate degree from the University of East Anglia and a doctorate from the University of Nottingham.
Former positions of Peter Greaney
| Companies | Position | End |
|---|---|---|
| CELGENE | Chief Operating Officer | 2017-12-31 |
| ADC THERAPEUTICS SA | Corporate Officer/Principal | - |
Training of Peter Greaney
| University of East Anglia | Undergraduate Degree |
| The University of Nottingham | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Peter Greaney